Psychomotor symptoms of depression are understudied despite having a severe impact on
patient outcomes. This review aims to summarize the evidence on motor features of …

Psychomotor slowing is a key feature of depressive disorders. Despite its great clinical
importance, the pathophysiology and prevalence across different diagnoses and mood …

Up to 70% of patients with major depressive disorder present with psychomotor disturbance
(PmD), but at the present time understanding of its pathophysiology is limited. In this study …

Background Structural and functional alterations of the anterior cingulate cortex (ACC) have
been related to emotional, cognitive and behavioral domains of major depressive disorder …

Introduction: Electroconvulsive therapy (ECT) influences the concentration of peripheral
inflammatory markers, such as interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α). In …

Psychomotor slowing is frequently distressing patients with depression and schizophrenia.
Increased neural activity within premotor cortices is linked to psychomotor slowing. This …

Two recent clinical trials, KetECT and ELEKT-D, compared the effectiveness of ketamine
and electroconvulsive therapy (ECT) for major depressive disorder. Notably, these trials …

Objective The Montreal Cognitive Assessment (MoCA) is a sensitive and clinically practical
test but its usefulness in measuring long‐term cognitive effects of ECT is unclear. Using the …

Objective: Several clinical variables assumed to be predictive of electroconvulsive therapy
(ECT) outcome in major depressive disorder show substantial interrelations. The current …

Purpose Misdiagnosis and ineffective treatment are common in major depressive disorder
(MDD) in current clinical practice, while the combination of various serum proteins may …